X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6565) 6565
Publication (1340) 1340
Book Review (44) 44
Book Chapter (15) 15
Conference Proceeding (5) 5
Dissertation (4) 4
Book / eBook (2) 2
Newspaper Article (1) 1
Presentation (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4600) 4600
index medicus (4132) 4132
animals (2949) 2949
signal transduction (1990) 1990
janus kinase 2 - genetics (1984) 1984
mice (1811) 1811
male (1710) 1710
mutation (1681) 1681
female (1674) 1674
janus kinase 2 (1456) 1456
hematology (1449) 1449
oncology (1391) 1391
phosphorylation (1372) 1372
janus kinase 2 - metabolism (1134) 1134
cell biology (1094) 1094
activation (993) 993
biochemistry & molecular biology (968) 968
middle aged (968) 968
expression (907) 907
kinases (880) 880
genetic aspects (878) 878
gene expression (870) 870
adult (842) 842
proteins (835) 835
research (831) 831
protein-tyrosine kinases - metabolism (830) 830
polycythemia-vera (813) 813
signal transduction - drug effects (810) 810
aged (804) 804
janus kinases - metabolism (791) 791
stat3 transcription factor - metabolism (767) 767
cytokines (748) 748
cell line, tumor (747) 747
apoptosis (742) 742
janus kinase (735) 735
immunology (702) 702
cell line (694) 694
cancer (672) 672
jak2 (668) 668
article (663) 663
essential thrombocythemia (635) 635
cells, cultured (627) 627
myeloproliferative disorders - genetics (613) 613
analysis (552) 552
stat transcription factors - metabolism (538) 538
research article (535) 535
health aspects (526) 526
myeloproliferative disorders (523) 523
dna-binding proteins - metabolism (520) 520
multidisciplinary sciences (516) 516
janus kinase 1 (513) 513
trans-activators - metabolism (507) 507
cells (506) 506
leukemia (497) 497
tumors (494) 494
myelofibrosis (473) 473
hemic and lymphatic diseases (471) 471
inflammation (470) 470
transcription (464) 464
gene-expression (463) 463
janus kinase 2 - antagonists & inhibitors (460) 460
medicine (460) 460
myeloproliferative neoplasms (449) 449
tyrosine kinase jak2 (449) 449
cell proliferation (438) 438
rats (438) 438
aged, 80 and over (437) 437
signal transduction - physiology (436) 436
proto-oncogene proteins (428) 428
stat3 (427) 427
abridged index medicus (425) 425
genes (418) 418
receptor (394) 394
rodents (387) 387
physiological aspects (385) 385
polycythemia vera - genetics (377) 377
science (374) 374
stat3 transcription factor - genetics (372) 372
janus kinase 1 - metabolism (371) 371
medicine, research & experimental (371) 371
care and treatment (361) 361
inhibition (359) 359
protein-tyrosine kinases - genetics (356) 356
molecular sequence data (354) 354
transfection (354) 354
mice, inbred c57bl (352) 352
signaling (351) 351
stat3 protein (349) 349
gene expression regulation (344) 344
risk factors (341) 341
thrombocythemia, essential - genetics (338) 338
transcription factors (334) 334
janus kinases - genetics (323) 323
primary myelofibrosis - genetics (323) 323
protein kinase inhibitors - pharmacology (322) 322
stem cells (320) 320
apoptosis - drug effects (315) 315
cell proliferation - drug effects (313) 313
genetics & heredity (313) 313
phosphorylation - drug effects (309) 309
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6491) 6491
Chinese (52) 52
French (12) 12
Japanese (10) 10
German (6) 6
Croatian (1) 1
Korean (1) 1
Polish (1) 1
Portuguese (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Cancer Cell, ISSN 1535-6108, 04/2015, Volume 27, Issue 4, pp. 516 - 532
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2016, Volume 375, Issue 9, pp. 819 - 829
Journal Article
Nature, ISSN 0028-0836, 09/2012, Volume 489, Issue 7414, pp. 155 - 159
The identification of somatic activating mutations in JAK2 (refs 1-4) and in the thrombopoietin receptor gene (MPL)(5) in most patients with myeloproliferative... 
MYELOFIBROSIS | LUNG-CANCER | POLYCYTHEMIA-VERA | GEFITINIB | MYELOPROLIFERATIVE DISORDERS | TYROSINE KINASE | MULTIDISCIPLINARY SCIENCES | BCR-ABL | MUTATION | RESISTANCE | CHRONIC MYELOID-LEUKEMIA | Myeloproliferative Disorders - enzymology | Phosphorylation | Protein Biosynthesis | Humans | Protein Multimerization | STAT Transcription Factors - metabolism | TYK2 Kinase - metabolism | Janus Kinase 1 - deficiency | TYK2 Kinase - deficiency | Myeloproliferative Disorders - pathology | Janus Kinase 1 - biosynthesis | Gene Knockdown Techniques | Janus Kinase 2 - deficiency | Janus Kinase 1 - metabolism | Granulocytes - drug effects | RNA Interference | Janus Kinase 1 - genetics | Janus Kinase 2 - metabolism | Myeloproliferative Disorders - metabolism | Granulocytes - metabolism | Janus Kinase 2 - antagonists & inhibitors | Disease Models, Animal | Cell Line | Janus Kinase 2 - genetics | Myeloproliferative Disorders - drug therapy | Enzyme Activation - drug effects | TYK2 Kinase - biosynthesis | Granulocytes - enzymology | Animals | Signal Transduction - drug effects | HSP90 Heat-Shock Proteins - antagonists & inhibitors | HSP90 Heat-Shock Proteins - metabolism | Mice | TYK2 Kinase - genetics | Drug Resistance, Neoplasm - drug effects | Enzyme inhibitors | Gene mutations | Cancer cells | Dosage and administration | Genetic aspects | Cellular signal transduction | Identification and classification | Physiological aspects | Care and treatment | Research | Myeloproliferative disorders | Cancer | tyrosine kinase inhibitors | persistence | MPN | JAK2 | resistance
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 6/2009, Volume 106, Issue 23, pp. 9414 - 9418
Journal Article
Blood, ISSN 0006-4971, 10/2012, Volume 120, Issue 17, pp. 3510 - 3518
CRLF2 rearrangements, JAK1/2 point mutations, and JAK2 fusion genes have been identified in Philadelphia chromosome (Ph)-like acute lymphoblastic leukemia... 
MAMMALIAN TARGET | RAPAMYCIN | IN-VITRO | ABERRANT STAT5 | RECEPTOR | OF-FUNCTION MUTATIONS | HEMATOLOGY | B-PROGENITOR | GENETIC ALTERATIONS | STAT5 ACTIVATION | CRLF2 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - metabolism | TOR Serine-Threonine Kinases - metabolism | Humans | Immunoglobulins - genetics | Molecular Targeted Therapy | Immunoglobulins - metabolism | TOR Serine-Threonine Kinases - antagonists & inhibitors | Janus Kinase 1 - metabolism | STAT5 Transcription Factor - genetics | STAT5 Transcription Factor - metabolism | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | TOR Serine-Threonine Kinases - genetics | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - mortality | Janus Kinase 1 - genetics | Janus Kinase 2 - metabolism | Antineoplastic Agents - pharmacology | Gene Expression Regulation, Neoplastic - drug effects | Receptors, Cytokine - metabolism | Drug Evaluation, Preclinical | Child | Philadelphia Chromosome | Receptors, Cytokine - genetics | Janus Kinase 2 - antagonists & inhibitors | Disease Models, Animal | Pyrazoles - pharmacology | Acute Disease | Janus Kinase 2 - genetics | Survival Rate | Signal Transduction - genetics | Janus Kinase 1 - antagonists & inhibitors | Sirolimus - pharmacology | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - genetics | Xenograft Model Antitumor Assays | Animals | Signal Transduction - drug effects | Mice | Protein Kinase Inhibitors - pharmacology | Lymphoid Neoplasia
Journal Article
Journal Article
Blood, ISSN 0006-4971, 06/2010, Volume 115, Issue 25, pp. 5232 - 5240
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2016, Volume 138, Issue 6, pp. 1752 - 1755
Journal Article
Molecular Carcinogenesis, ISSN 0899-1987, 02/2013, Volume 52, Issue 2, pp. 155 - 166
The Janus kinase (JAK)/signal transducer and activator of transcription (STAT) signaling pathway is involved in immune function and cell growth. We evaluated... 
cigarette smoking | STAT | estrogen | JAK | colon cancer | NSAIDs | rectal cancer | SOCS | Colon cancer | Rectal cancer | Estrogen | Cigarette smoking | OXIDATIVE STRESS | ACTIVATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | TRANSCRIPTION | RISK | ENERGY-BALANCE | INHIBITION | ONCOLOGY | JANUS KINASES | COLORECTAL-CANCER | INFLAMMATION | PHYSICAL-ACTIVITY | Smoking - adverse effects | Colonic Neoplasms - genetics | Receptors, Estrogen - metabolism | Colorectal Neoplasms - genetics | Humans | Middle Aged | STAT Transcription Factors - metabolism | STAT4 Transcription Factor - metabolism | TYK2 Kinase - metabolism | Suppressor of Cytokine Signaling 1 Protein | Male | Janus Kinases - metabolism | Interferon-gamma - metabolism | Case-Control Studies | Colonic Neoplasms - metabolism | Janus Kinase 1 - metabolism | STAT1 Transcription Factor - metabolism | Rectal Neoplasms - genetics | Janus Kinase 1 - genetics | Janus Kinase 2 - metabolism | Adult | Female | Interferon-gamma - genetics | Interleukin-6 - metabolism | Colorectal Neoplasms - metabolism | STAT3 Transcription Factor - genetics | STAT3 Transcription Factor - metabolism | Colonic Neoplasms - mortality | Genetic Predisposition to Disease | Interleukin-6 - genetics | Janus Kinases - genetics | Signal Transduction | Janus Kinase 2 - genetics | Suppressor of Cytokine Signaling Proteins - genetics | Survival Rate | STAT1 Transcription Factor - genetics | Rectal Neoplasms - mortality | STAT Transcription Factors - genetics | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | STAT4 Transcription Factor - genetics | Aged | Polymorphism, Single Nucleotide | Rectal Neoplasms - metabolism | Suppressor of Cytokine Signaling Proteins - metabolism | TYK2 Kinase - genetics | Aspirin | Analysis | Oncology, Experimental | Research | Public health | Smoking | Cancer | Genetic diversity | Kinases | Risk factors | Colorectal cancer
Journal Article
Cancer Discovery, ISSN 2159-8274, 02/2017, Volume 7, Issue 2, pp. 188 - 201
Journal Article